Publication Author: Zeliadt_Steven

• Racial disparity in primary and adjuvant treatment for nonmetastatic prostate cancer: SEER-Medicare trends 1991 to 1999.

  Zeliadt SB, Potosky AL, Etzioni R, Ramsey SD, Penson DF. Racial disparity in primary and adjuvant treatment for nonmetastatic prostate cancer: SEER-Medicare trends 1991 to 1999. Urology. 2004 Dec;64(6):1171-6.

  rakerr2

  December 1, 2004

• Localized prostate cancer: quality of life meets Whitmore’s legacy.

  Bermejo C, Kristal AR, Zeliadt SB, Ramsey S, Thompson IM. Localized prostate cancer: quality of life meets Whitmore’s legacy. J Natl Cancer Inst. 2004 Sep 15;96(18):1348-9.

  rakerr2

  September 15, 2004

• Race independently predicts prostate specific antigen testing frequency following a prostate carcinoma diagnosis.

  Zeliadt SB, Penson DF, Albertsen PC, Concato J, Etzioni RD. Race independently predicts prostate specific antigen testing frequency following a prostate carcinoma diagnosis. Cancer. 2003 Aug 1;98(3):496-503.

  rakerr2

  August 1, 2003